The first Marketplace for innovations, patents and investments.

Automate the generation of B2B opportunities by combining AI, automation, and data in a single environment. With Synapsale, you can search, contact, and schedule meetings with potential clients without relying on multiple tools or expanding your sales team. It enables sales teams and founders to save up to 70% of operational time and increase conversions by 30%, thanks to an intelligent workflow that integrates: Advanced search for leads segmented by industry, role, or location. Multi-channel messaging (LinkedIn + email) with contextual AI. Real-time dashboard with performance metrics and pipeline tracking. AI sales assistant that suggests messages, success stories, and resources tailored to each lead.

*price per monthly susbcription license

This repor includes an economic Assessment Report and Proposed Commercialisation Strategy for a New CO2 Removal Technology

This market research includes:
1) A literature review.
2) An objective quantitation of gluten-free bread and bakery products in European markets.
3) Figures and tables estimating price of gluten-free products in European countries.

The global nanomedicine market, valued at USD 195 billion in 2025, is projected to grow at a CAGR of 15–20% if key industry challenges are resolved, reaching USD 392–485 billion by 2030. This report outlines the market forecast, key growth barriers, competitive landscape, and the strategic positioning.

The liquid biopsy and precision diagnostics market is experiencing unprecedented acceleration driven by the paradigm shift toward non-invasive, early-stage cancer detection.
This optimistic trajectory significantly outpaces the conservative 6.4% CAGR projected in broader liver cancer diagnostics reports, assuming successful resolution of key barriers including standardization, reimbursement accessibility, and regulatory frameworks.

The global 3D bioprinted human tissue market represents one of the most promising frontiers in biotechnology, combining cutting-edge manufacturing with life-saving medical applications. This revolutionary field is transforming how we approach drug testing, cosmetic development, and regenerative medicine.

The market presents a significant opportunity for innovative technologies like TokaTrac's hybrid drivetrain, which offers a strategic bridge between internal combustion engines (ICE) and fully electric vehicles (EVs), positioning itself at the forefront of this market transformation.

PubChem CID: 10107266
CAS: 3843-71-4
Synonyms: • (E)-1,3-bis(2,4-dihydroxyphenyl)prop-2-en-1-one Mol. Formula/ MW/Monoisotopic mass: C15H12O5 272.25 g/mol 272.06847348 g/mol
Purity %: >90 (HPLC and mass spectrometric analysis included in the price) *Lower amounts may be available upon request